UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lipocalin 2 negatively regulates cell proliferation and epithelial to mesenchymal transition through changing metabolic gene expression in colorectal cancer

Cancer science, 2017-11, Vol.108 (11), p.2176-2186

2017

Volltextzugriff (PDF)

Lipocalin 2 potentially contributes to tumorigenesis from colitis via IL-6/STAT3/NF-κB signaling pathway

Bioscience reports, 2022-05, Vol.42 (5), p.1

2022

Volltextzugriff (PDF)

MiRNA-206 suppresses PGE2-induced colorectal cancer cell proliferation, migration, and invasion by targetting TM4SF1

Bioscience reports, 2018-10, Vol.38 (5)

2018

Volltextzugriff (PDF)

Combined Parthenolide and Balsalazide Have Enhanced Antitumor Efficacy Through Blockade of NF-κB Activation

Molecular cancer research, 2017-02, Vol.15 (2), p.141-151

2017

Volltextzugriff (PDF)

HDAC inhibitor SB939 potentiates TRAIL-induced apoptosis in colorectal cancer cells

Cellular and Molecular Biology, 2023-05, Vol.69 (5), p.12-18

2023

Volltextzugriff (PDF)

Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPK-mediated DR5 regulation in colorectal cancer

International journal of oncology, 2018-12, Vol.53 (6), p.2789-2799

2018

Volltextzugriff (PDF)

Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells

Cancer genetics, 2019-02, Vol.231-232, p.22-31

2019

Volltextzugriff (PDF)

Synergistic antitumor effect of 5-fluorouracil in combination with parthenolide in human colorectal cancer

Cancer letters, 2013-07, Vol.335 (2), p.479-486

2013

Volltextzugriff (PDF)

Anti-angiogenic and anti-tumor activity of Bavachinin by targeting hypoxia-inducible factor-1α

European journal of pharmacology, 2012-09, Vol.691 (1-3), p.28-37

2012

Volltextzugriff (PDF)

SPION-loaded chitosan–linoleic acid nanoparticles to target hepatocytes

International journal of pharmaceutics, 2009-04, Vol.371 (1), p.163-169

2009

Volltextzugriff (PDF)

Superparamagnetic iron oxide nanoparticles-loaded chitosan-linoleic acid nanoparticles as an effective hepatocyte-targeted gene delivery system

International journal of pharmaceutics, 2009-05, Vol.372 (1), p.169-176

2009

Volltextzugriff (PDF)

Folate receptor targeted imaging using poly (ethylene glycol)-folate: in vitro and in vivo studies

Journal of Korean Medical Science, 2007, 22(3), , pp.405-411

2007

Volltextzugriff (PDF)

Parthenolide promotes apoptotic cell death and inhibits the migration and invasion of SW620 cells

Intestinal research, 2017, 15(2), , pp.174-181

2017

Volltextzugriff (PDF)

Balsalazide Potentiates Parthenolide-Mediated Inhibition of Nuclear Factor-κB Signaling in HCT116 Human Colorectal Cancer Cells

Intestinal research, 2015-07, Vol.13 (3), p.233-241

2015

Volltextzugriff (PDF)

Parthenolide enhances sensitivity of colorectal cancer cells to TRAIL by inducing death receptor 5 and promotes TRAIL-induced apoptosis

International journal of oncology, 2015-03, Vol.46 (3), p.1121-1130

2015

Volltextzugriff (PDF)

Parthenolide suppresses tumor growth in a xenograft model of colorectal cancer cells by inducing mitochondrial dysfunction and apoptosis

International journal of oncology, 2012-10, Vol.41 (4), p.1547-1553

2012

Volltextzugriff (PDF)

Parthenolide Sensitizes Human Colorectal Cancer Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand through Mitochondrial and Caspase Dependent Pathway

Intestinal research, 2014, 12(1), , pp.34-41

2014

Volltextzugriff (PDF)

The effect of PPAR-gamma agonist on (18)F-FDG uptake in tumor and macrophages and tumor cells

Nuclear medicine and biology, 2009-05, Vol.36 (4), p.427-433

2009

Volltextzugriff (PDF)

Synergistic Effect of Parthenolide in Combination with 5-Fluorouracil in SW480 Cells

Intestinal Research, 2012-10, Vol.10 (4), p.357

2012

Volltextzugriff (PDF)

Acquired Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Resistance of Human Colorectal Cancer Cells Is Linked to Histone Acetylation and Is Synergistically Ameliorated by Combination with HDAC Inhibitors

Digestive diseases and sciences, 2024-09, Vol.69 (9), p.3305-3317

2024

Volltextzugriff (PDF)

Parthenolide suppresses hypoxia-inducible factor-1α signaling and hypoxia induced epithelial-mesenchymal transition in colorectal cancer

International journal of oncology, 2017-12, Vol.51 (6), p.1809-1820

2017

Volltextzugriff (PDF)

Lipocalin 2 activates the NLRP3 inflammasome via LPS‑induced NF‑κB signaling and plays a role as a pro‑inflammatory regulator in murine macrophages

Molecular medicine reports, 2022-12, Vol.26 (6), Article 358

2022

Volltextzugriff (PDF)

Lipocalin 2 activates the NLRP3 inflammasome via LPS-induced NF-[kappa]B signaling and plays a role as a pro-inflammatory regulator in murine macrophages

Molecular medicine reports, 2022-12, Vol.26 (6)

2022

Volltextzugriff (PDF)

Preproghrelin Leu72Met polymorphism in obese Korean children

Journal of Pediatric Endocrinology and Metabolism, 2005-11, Vol.18 (11), p.1083

2005

Volltextzugriff (PDF)

A novel HDAC1 inhibitor, CBUD‑1001, exerts anticancer effects by modulating the apoptosis and EMT of colorectal cancer cells

International journal of oncology, 2020-10, Vol.57 (4), p.1027-1038

2020

Volltextzugriff (PDF)

1 – 25 von 344

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(238)
Mit Volltextzugriff
(243)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Lipocalin 2 negatively regulates cell proliferation and epithelial to mesenchymal transition through changing metabolic gene expression in colorectal cancer

Lipocalin 2 potentially contributes to tumorigenesis from colitis via IL-6/STAT3/NF-κB signaling pathway

MiRNA-206 suppresses PGE2-induced colorectal cancer cell proliferation, migration, and invasion by targetting TM4SF1

Combined Parthenolide and Balsalazide Have Enhanced Antitumor Efficacy Through Blockade of NF-κB Activation

HDAC inhibitor SB939 potentiates TRAIL-induced apoptosis in colorectal cancer cells

Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPK-mediated DR5 regulation in colorectal cancer

Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells

Synergistic antitumor effect of 5-fluorouracil in combination with parthenolide in human colorectal cancer

Anti-angiogenic and anti-tumor activity of Bavachinin by targeting hypoxia-inducible factor-1α

SPION-loaded chitosan–linoleic acid nanoparticles to target hepatocytes

Superparamagnetic iron oxide nanoparticles-loaded chitosan-linoleic acid nanoparticles as an effective hepatocyte-targeted gene delivery system

Folate receptor targeted imaging using poly (ethylene glycol)-folate: in vitro and in vivo studies

Parthenolide promotes apoptotic cell death and inhibits the migration and invasion of SW620 cells

Balsalazide Potentiates Parthenolide-Mediated Inhibition of Nuclear Factor-κB Signaling in HCT116 Human Colorectal Cancer Cells

Parthenolide enhances sensitivity of colorectal cancer cells to TRAIL by inducing death receptor 5 and promotes TRAIL-induced apoptosis

Parthenolide suppresses tumor growth in a xenograft model of colorectal cancer cells by inducing mitochondrial dysfunction and apoptosis

Parthenolide Sensitizes Human Colorectal Cancer Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand through Mitochondrial and Caspase Dependent Pathway

The effect of PPAR-gamma agonist on (18)F-FDG uptake in tumor and macrophages and tumor cells

Synergistic Effect of Parthenolide in Combination with 5-Fluorouracil in SW480 Cells

Acquired Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Resistance of Human Colorectal Cancer Cells Is Linked to Histone Acetylation and Is Synergistically Ameliorated by Combination with HDAC Inhibitors

Parthenolide suppresses hypoxia-inducible factor-1α signaling and hypoxia induced epithelial-mesenchymal transition in colorectal cancer

Lipocalin 2 activates the NLRP3 inflammasome via LPS‑induced NF‑κB signaling and plays a role as a pro‑inflammatory regulator in murine macrophages

Lipocalin 2 activates the NLRP3 inflammasome via LPS-induced NF-[kappa]B signaling and plays a role as a pro-inflammatory regulator in murine macrophages

Preproghrelin Leu72Met polymorphism in obese Korean children

A novel HDAC1 inhibitor, CBUD‑1001, exerts anticancer effects by modulating the apoptosis and EMT of colorectal cancer cells

Suchergebnisse filtern